OptimizeRx Corporation logo
OptimizeRx Corporation OPRX
$ 13.18 -1.35%

Quarterly report 2025-Q3
added 11-07-2025

report update icon

OptimizeRx Corporation Cash Flow 2011-2025 | OPRX

Annual Cash Flow OptimizeRx Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-7.24 M 10.7 M 726 K -6.31 M -1.66 M 793 K -1.48 M -466 K 515 K -56.4 K 1.13 M -624 K -522 K

Depreciation & Amortization

2.4 M 2.02 M 1.97 M 2.08 M 1.28 M 317 K 325 K 235 K 334 K 264 K 194 K 187 K 145 K

Accounts Payables

2.23 M 1.55 M 607 K 618 K 493 K 411 K 457 K 369 K 212 K 200 K 189 K 54.7 K 337 K

Accounts Receivables

36.3 M 22.2 M 24.8 M 17.9 M 7.42 M 6.46 M 2.26 M 3.06 M 2.85 M 2.1 M 1.51 M - -

All numbers in USD currency

Quarterly Cash Flow OptimizeRx Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - 3.86 M - - - 2.12 M - - - -86 K - 7.85 M 4.39 M 4.08 M - 2.06 M 1.86 M 1.67 M - -3.72 M -3.61 M -3.74 M - -161 K 808 K 890 K - -140 K -1.22 M -787 K - -1.49 M -696 K -297 K - - -177 K -286 K - 488 K 246 K 86.7 K - -329 K -150 K 227 K - 303 K -106 K 6.5 K - -626 K -376 K -128 K - -604 K -225 K -91.6 K

Depreciation & Amortization

1.08 M 1.07 M 1.09 M - 1.1 M 1.07 M 1.07 M - 467 K 465 K 464 K - 516 K 578 K 472 K - 1.58 M 1.05 M - - - - 520 K - 746 K 426 K 190 K - 163 K 109 K 54.5 K - 213 K 142 K 71 K - 154 K 101 K 50.3 K - 242 K 159 K 79.7 K - 182 K 116 K 58.9 K - 48.2 K 48.2 K 48.1 K - 46.7 K 47.3 K 46 K - 30 K 30 K 30 K

Accounts Payables

2.04 M 1.98 M 3.38 M 2.16 M 2.75 M 2.98 M 1.66 M 2.23 M 691 K 818 K 1.29 M 1.55 M 1 M 1.3 M 601 K 607 K 772 K 805 K 499 K 618 K 618 K 618 K 618 K 493 K 493 K 493 K 493 K 411 K 411 K 411 K 411 K 457 K 457 K 457 K 457 K 369 K 369 K 369 K 369 K 212 K 212 K 212 K 212 K 200 K 200 K 200 K 200 K 189 K 189 K 189 K 189 K 54.7 K 54.7 K 54.7 K 54.7 K 337 K 337 K 337 K 337 K

Accounts Receivables

32.2 M 33.5 M 32.7 M 38.2 M 26.3 M 24.5 M 29.7 M 36.3 M 4.6 M 2.98 M 2.99 M 3.58 M 3.51 M 3.85 M 2.82 M 2.11 M 757 K 1.22 M 14.7 M 77.5 K 17.9 M 77.5 K 17.9 M 7.42 M 7.42 M 7.42 M 7.42 M 6.46 M 6.46 M 6.46 M 6.46 M 3.43 M 2.26 M 2.26 M 2.26 M 1.95 M 3.06 M 3.06 M 3.06 M 2.85 M 2.85 M 2.85 M 2.85 M 2.1 M 2.1 M 2.1 M 2.1 M 1.51 M 1.57 M - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company OptimizeRx Corporation, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Health information services sector

Issuer Price % 24h Market Cap Country
Cerner Corporation Cerner Corporation
CERN
- - $ 27.9 B usaUSA
Computer Programs and Systems Computer Programs and Systems
CPSI
- 4.4 % $ 133 M usaUSA
Covetrus Covetrus
CVET
- - $ 2.94 B usaUSA
Accolade Accolade
ACCD
- 0.29 % $ 206 M usaUSA
Change Healthcare Change Healthcare
CHNG
- - $ 9.03 B usaUSA
Evolent Health Evolent Health
EVH
$ 4.11 -0.48 % $ 385 M usaUSA
Health Catalyst Health Catalyst
HCAT
$ 2.34 -4.82 % $ 141 M usaUSA
HealthStream HealthStream
HSTM
$ 24.4 0.95 % $ 741 M usaUSA
iCAD iCAD
ICAD
- - $ 102 M usaUSA
Akerna Corp. Akerna Corp.
KERN
- - $ 161 M usaUSA
HealthEquity HealthEquity
HQY
$ 96.06 -0.75 % $ 8.22 B usaUSA
American Well Corporation American Well Corporation
AMWL
$ 4.68 1.3 % $ 70.2 M usaUSA
Allscripts Healthcare Solutions Allscripts Healthcare Solutions
MDRX
- -10.39 % $ 886 M usaUSA
Progyny Progyny
PGNY
$ 26.39 -1.2 % $ 2.26 B usaUSA
Premier Premier
PINC
$ 28.26 - $ 2.33 B usaUSA
MTBC MTBC
MTBC
- -0.58 % $ 51.7 M usaUSA
GoodRx Holdings GoodRx Holdings
GDRX
$ 2.72 -3.72 % $ 1.05 B usaUSA
Schrödinger Schrödinger
SDGR
$ 18.41 1.99 % $ 1.34 B usaUSA
Omnicell Omnicell
OMCL
$ 43.31 -1.25 % $ 1.99 B usaUSA
1Life Healthcare 1Life Healthcare
ONEM
- - $ 3.37 B usaUSA
Phreesia Phreesia
PHR
$ 16.68 2.71 % $ 910 M usaUSA
So-Young International So-Young International
SY
$ 2.92 -5.66 % $ 232 M chinaChina
Signify Health Signify Health
SGFY
- -0.02 % $ 7.21 B usaUSA
R1 RCM R1 RCM
RCM
- - $ 3.81 B usaUSA
10x Genomics 10x Genomics
TXG
$ 15.77 2.01 % $ 1.85 B usaUSA
NantHealth NantHealth
NH
- -46.64 % $ 10.4 M usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
- - $ 1.6 B usaUSA
Veeva Systems Veeva Systems
VEEV
$ 219.17 -1.81 % $ 35.2 B usaUSA
Zhongchao Zhongchao
ZCMD
$ 0.58 -3.18 % $ 3.02 M chinaChina
Streamline Health Solutions Streamline Health Solutions
STRM
- - $ 21.4 M usaUSA
Teladoc Health Teladoc Health
TDOC
$ 7.36 -2.65 % $ 1.26 B usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
- - $ 255 M usaUSA
SCWorx Corp. SCWorx Corp.
WORX
$ 0.21 5.86 % $ 306 K usaUSA